xodcode
6 minutes ago
It isn't just the MAA, too - 3-71 readout is coming and P3 trials are starting for PD and supposedly for other indications. And let's hope some analyst asks about NDA at JPM, too.
Yes, good point, and all that is progressing with the rest of the AVXL pipeline just adds fuel to the sug